Transvaginal mesh trial losses put pressure on Boston Scientific

NEW YORK (Reuters) – Boston Scientific Corp’s back-to-back losses in the first two federal trials over its transvaginal mesh devices could drive up the cost of resolving thousands of similar lawsuits, according to legal experts.

On Thursday, a jury in West Virginia awarded four women $18.5 million for injuries they said were caused by the Massachusetts-based company’s Obtryx device for stress urinary incontinence, including $4 million for “gross negligence.”…

Read More >>